VCEL Stock Balance Sheets

Vericel Quarterly Balance Sheets Chart

Quarterly

Annual

Account Receivables

Cash and Cash Eq

Account Payables

Inventory

Vericel Quarterly Balance Sheets Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-06-30	2010-03-31	2009-06-30	2009-03-31	2008-06-30	2008-03-31	2007-06-30	2007-03-31	2006-06-30	2006-03-31	2005-06-30	2005-03-31	2004-06-30	2004-03-31	2003-06-30	2003-03-31	2002-06-30	2002-03-31	2001-06-30

assets
current assets:
cash and cash equivalents	80,532,000	73,490,000	74,520,000	53,681,000	50,291,000	62,938,000	69,088,000	60,473,000	43,023,000	61,834,000	51,067,000	65,216,000	56,054,000	55,659,000	68,330,000	54,553,000	51,761,000	58,154,000	33,620,000	43,507,000	55,704,000	45,623,000	26,889,000	36,905,000	13,962,000	35,084,000	18,286,000	53,289,000	94,969,000																			10,816,000	4,494,000	9,226,000	13,638,000	21,089,000	28,666,000	36,733,000	5,530,000	11,947,000	18,521,000	24,621,000	14,119,000	17,844,000	17,000,000	19,076,000	16,492,000	26,713,000	13,439,000	27,608,000	9,034,000	12,838,000	14,408,000	13,494,000	16,926,000	10,426,000	10,512,000	5,064,000	8,605,000	10,953,000	10,659,000
restricted cash		6,215,000	10,529,000	16,669,000	25,563,000	7,804,000	17,778,000	23,088,000	27,794,000				6,184,000	6,184,000	211,000	211,000	211,000	211,000	211,000	211,000	89,000	89,000	89,000
short-term investments	36,349,000	39,412,000	41,693,000	48,053,000	52,217,000	47,710,000	40,469,000	44,870,000	54,808,000	57,442,000	68,471,000	45,724,000	44,638,000	44,888,000	35,068,000	43,738,000	39,214,000	25,402,000	42,187,000	42,035,000				37,760,000	52,047,000																																		5,000,000	5,000,000			5,970,000		14,886,000	4,999,000	33,963,000	9,500,000	18,006,000	21,941,000					1,000,000	1,000,000
accounts receivable	64,290,000	52,899,000	61,375,000	48,479,000	47,996,000	49,934,000	58,356,000	39,729,000	38,319,000	38,359,000	46,539,000	34,296,000	33,664,000	31,855,000	37,437,000	28,910,000	31,732,000	29,122,000	34,504,000	26,174,000	23,655,000	24,171,000	32,168,000	19,958,000	21,084,000	18,774,000	23,454,000	15,528,000	17,499,000	13,162,000	18,270,000	15,430,000	14,729,000	12,127,000	17,093,000	7,871,000	9,031,000	9,669,000	10,919,000	7,639,000	8,980,000	9,166,000	8,191,000	3,959,000	4,317,000
inventory	16,831,000	17,106,000	17,373,000	15,756,000	14,887,000	13,557,000	13,087,000	12,621,000	13,883,000	15,370,000	15,986,000	16,729,000	15,929,000	14,385,000	13,381,000	13,059,000	12,959,000	10,322,000	9,356,000	10,080,000	8,417,000	7,282,000	6,816,000	6,823,000	4,788,000	4,063,000	3,558,000	3,638,000	3,725,000	3,905,000	3,793,000	4,049,000	3,155,000	3,958,000	3,488,000	3,607,000	2,393,000	1,942,000	1,379,000	1,639,000	2,078,000	2,005,000	1,920,000	1,711,000	1,922,000																									226,000	389,000		806,000	1,132,000	1,397,000	994,000	725,000
other current assets	6,575,000	8,518,000	7,287,000	7,882,000	6,432,000	7,775,000	6,853,000	5,430,000	5,044,000	4,540,000	4,803,000	4,410,000	4,809,000	5,093,000	4,246,000	4,686,000	2,854,000	4,213,000	3,893,000	3,586,000	2,900,000	3,504,000	2,953,000	3,272,000	2,167,000	2,679,000	2,847,000	2,339,000	1,327,000	1,358,000	1,581,000	1,366,000	1,116,000	1,018,000	1,164,000	741,000	1,046,000	662,000	464,000	514,000	2,270,000	845,000	1,036,000	1,468,000	610,000	400,000	417,000	545,000	236,000	300,000	324,000	364,000	455,000	453,000	636,000	622,000	524,000	439,000	383,000	591,000	732,000	959,000	1,583,000	1,865,000	1,766,000	478,000	528,000	447,000	421,000	471,000	271,000	483,000	185,000	454,000	225,000	350,000	213,000
total current assets	204,577,000	197,640,000	212,777,000	190,520,000	197,386,000	189,718,000	205,631,000	186,211,000	182,871,000	177,545,000	186,866,000	166,375,000	155,094,000	151,880,000	158,462,000	144,946,000	138,520,000	127,213,000	123,560,000	125,382,000	115,762,000	116,537,000	111,655,000	104,718,000	94,048,000	109,601,000	112,783,000	119,256,000	117,520,000	48,202,000	50,506,000	36,311,000	33,041,000	36,950,000	44,723,000	21,099,000	22,305,000	25,817,000	27,343,000	28,516,000	33,546,000	37,919,000	41,490,000	44,716,000	14,112,000	9,236,000	8,476,000	11,361,000	4,730,000	9,526,000	13,990,000	21,462,000	29,130,000	37,197,000	6,175,000	12,578,000	19,045,000	25,078,000	19,518,000	23,435,000	17,791,000	20,289,000	24,063,000	28,641,000	30,177,000	33,189,000	43,665,000	22,980,000	33,144,000	36,391,000		11,863,000					11,726,000
property and equipment	109,848,000	108,294,000	103,161,000	88,413,000	73,086,000	56,392,000	41,635,000	30,216,000	23,408,000	18,197,000	15,837,000	15,918,000	15,919,000	14,451,000	13,308,000	11,819,000	10,590,000	9,076,000	7,633,000	7,115,000	7,040,000	7,423,000	7,144,000	7,190,000	6,963,000	6,445,000	5,906,000	5,207,000	4,673,000	4,207,000	4,071,000	3,967,000	3,493,000	3,638,000	3,875,000	4,215,000	4,351,000	4,393,000	4,049,000	4,315,000	4,616,000	3,446,000	2,892,000	2,398,000	2,387,000	642,000	739,000	841,000	953,000	1,056,000	1,188,000	1,246,000	1,309,000	1,467,000	1,564,000	1,494,000	1,259,000	1,153,000	1,013,000	1,134,000	1,485,000	1,666,000	2,154,000	2,321,000	2,671,000	1,380,000	1,216,000	1,101,000	753,000	614,000	334,000	308,000
intangible assets	5,938,000	6,094,000	6,250,000	6,406,000	6,563,000	6,719,000	6,875,000	7,031,000	7,188,000	7,344,000	7,500,000																									2,708,000	2,778,000	2,847,000	2,917,000	2,987,000	3,057,000	3,127,000	3,197,000	3,267,000	3,337,000
right-of-use assets	67,398,000	68,716,000	70,098,000	71,561,000	73,020,000	73,682,000	73,462,000	73,294,000	75,063,000	40,851,000	41,535,000	42,628,000	43,583,000	44,653,000	45,720,000	46,713,000	47,798,000	48,943,000	50,105,000			24,496,000	25,103,000	25,619,000	24,815,000	25,183,000
long-term investments	47,400,000	43,342,000	39,880,000	32,895,000	26,120,000	29,433,000	25,283,000	20,231,000	20,985,000	19,910,000	19,962,000	21,739,000	23,718,000	22,803,000	25,687,000	20,235,000	24,826,000	26,021,000	24,099,000
other long-term assets	447,000	501,000	556,000	610,000	664,000	717,000	771,000	1,142,000	1,196,000	1,249,000	1,303,000	1,357,000	317,000	317,000	317,000	219,000
total assets	435,608,000	424,587,000	432,722,000	390,405,000	376,839,000	356,661,000	353,657,000	318,125,000	310,711,000	265,096,000	273,003,000	248,017,000	244,815,000	240,288,000	243,705,000	224,143,000	221,945,000	211,464,000	205,608,000	157,504,000	146,691,000	150,265,000	153,238,000	137,527,000	125,826,000	141,229,000	118,689,000	124,463,000	122,193,000	52,409,000	54,577,000	40,278,000	36,534,000	40,588,000	48,598,000	28,022,000	29,434,000	33,057,000	34,309,000	35,818,000	41,219,000	44,492,000	47,579,000	50,381,000	19,836,000	9,878,000	9,215,000	12,202,000	5,683,000	10,582,000	15,178,000	22,708,000	30,439,000	38,664,000	7,739,000	14,072,000	20,304,000	26,231,000	20,531,000	24,569,000	19,276,000	21,955,000	26,217,000	30,962,000	32,848,000	34,569,000	44,881,000	24,081,000	33,897,000	37,005,000		12,171,000					11,905,000
liabilities and shareholders’ equity
current liabilities:
accounts payable	12,857,000	16,751,000	23,848,000	20,884,000	25,216,000	19,432,000	22,347,000	15,051,000	14,401,000	11,125,000	16,930,000	8,113,000	9,684,000	7,750,000	9,016,000	5,575,000	8,134,000	8,826,000	6,755,000	6,475,000	4,535,000	6,400,000	6,345,000	5,281,000	5,250,000	6,201,000	7,108,000	4,580,000	5,011,000	5,768,000	5,552,000	5,972,000	6,272,000	6,335,000	6,535,000	5,467,000	5,305,000	6,293,000	7,588,000	4,995,000	6,120,000	6,726,000	5,824,000
accrued expenses	14,404,000	11,418,000	17,065,000	14,343,000	12,856,000	11,026,000	17,215,000	13,628,000	13,971,000	13,111,000	16,190,000	13,948,000	12,133,000	10,793,000	14,045,000	10,932,000	11,077,000	9,965,000	11,293,000	8,695,000	7,975,000	6,149,000	7,948,000	6,960,000	4,701,000	4,179,000	6,930,000	5,592,000	5,111,000	4,007,000	5,573,000	4,514,000	4,135,000	6,030,000	4,523,000	3,398,000	2,892,000	4,943,000	3,603,000	3,311,000	3,258,000	4,320,000	4,714,000
current portion of operating lease liabilities	13,753,000	11,163,000	9,257,000	6,119,000	5,791,000	6,012,000	6,187,000	7,267,000	7,218,000	4,497,000	4,302,000	4,902,000	3,156,000	3,147,000	2,950,000	2,280,000	4,611,000	4,398,000	4,394,000	6,102,000	5,570,000	5,535,000	5,461,000	2,836,000	2,558,000	2,385,000
other current liabilities	118,000	116,000	116,000						21,000	20,000	41,000	41,000	41,000	41,000	41,000
total current liabilities	41,132,000	39,448,000	50,286,000	41,346,000	43,863,000	36,470,000	45,749,000	35,946,000	35,611,000	28,753,000	37,463,000	27,004,000	25,014,000	21,731,000	26,052,000	18,828,000	23,863,000	23,230,000	22,483,000	21,313,000	18,121,000	18,125,000	19,795,000	15,112,000	12,543,000	12,941,000	14,792,000	14,992,000	15,220,000	13,878,000	13,090,000	14,528,000	12,943,000	14,752,000	12,853,000	15,360,000	11,455,000	13,769,000	12,108,000	9,261,000	10,818,000	12,624,000	11,829,000	12,482,000	17,051,000	6,109,000	5,321,000	7,252,000	3,842,000	4,276,000	5,659,000	6,980,000	11,990,000	22,347,000	20,670,000	25,181,000	30,419,000	27,634,000	2,661,000	1,810,000	1,687,000	1,710,000	2,100,000	1,836,000	3,500,000	2,293,000	2,539,000	1,697,000	869,000	801,000		545,000					1,011,000
operating lease liabilities	86,011,000	87,804,000	89,593,000	91,344,000	89,801,000	86,141,000	81,856,000	77,734,000	76,144,000	42,365,000	43,268,000	43,176,000	44,964,000	46,053,000	47,147,000	48,493,000	46,928,000	47,968,000	48,789,000	21,487,000	20,881,000	21,597,000	22,242,000	25,311,000	24,607,000	25,100,000
other long-term liabilities	1,656,000	1,848,000	876,000	243,000	198,000	154,000	100,000	65,000	28,000				21,000	19,000	44,000	42,000	62,000	57,000	76,000	74,000	93,000	91,000	110,000	114,000	134,000	133,000														66,000	66,000	66,000
total liabilities	128,799,000	129,100,000	140,755,000	132,933,000	133,862,000	122,765,000	127,705,000	113,745,000	111,783,000	71,118,000	80,731,000	70,180,000	69,999,000	67,803,000	73,243,000	67,363,000	70,853,000	71,255,000	71,348,000	42,874,000	39,095,000	39,813,000	42,147,000	40,537,000	37,284,000	38,174,000	16,458,000	29,988,000	31,595,000	31,474,000	32,037,000	23,541,000	22,561,000	25,084,000	23,890,000	16,629,000	12,327,000	13,831,000	12,179,000	9,408,000	10,975,000	12,790,000		12,597,000			5,321,000	7,252,000	3,842,000	4,278,000	5,665,000	6,989,000	12,009,000	22,376,000
commitments and contingencies
shareholders’ equity:
common stock	711,240,000	699,412,000	684,778,000	669,735,000	654,971,000	641,180,000	629,229,000	621,013,000	612,059,000	602,104,000	593,245,000	584,900,000	575,011,000	563,475,000	553,902,000	544,624,000	534,005,000	519,360,000	510,061,000	502,587,000	499,103,000	493,774,000	489,749,000	485,141,000	480,050,000	474,806,000	471,180,000	468,447,000	463,483,000	389,074,000	383,020,000	377,711,000	369,540,000	368,683,000	329,720,000	310,208,000	309,437,000	308,512,000	307,766,000	307,207,000	306,625,000	305,931,000	305,008,000	304,780,000	262,789,000	259,140,000	253,270,000	251,358,000	245,976,000	245,550,000	243,215,000	242,771,000	239,448,000	229,868,000	228,877,000	227,901,000	226,967,000	225,722,000	231,343,000	231,059,000	213,107,000	211,683,000	203,211,000	203,242,000	187,995,000	187,191,000	184,492,000	160,238,000	158,703,000	158,519,000	131,472,000	122,743,000	114,951,000	107,372,000	104,600,000	104,601,000	96,752,000
accumulated other comprehensive gain	183,000	136,000		359,000
accumulated deficit	-404,614,000	-404,061,000	-392,815,000	-412,622,000	-411,721,000	-407,039,000	-403,177,000	-416,170,000	-412,510,000	-407,490,000	-399,995,000	-405,917,000	-399,340,000	-390,377,000	-383,286,000	-387,821,000	-382,890,000	-379,104,000	-375,815,000	-388,035,000	-391,653,000	-383,384,000	-378,679,000	-388,180,000	-391,650,000	-371,858,000	-369,014,000	-374,256,000	-373,187,000	-368,536,000	-360,877,000	-361,164,000	-355,757,000	-353,369,000	-343,591,000	-337,394,000	-330,719,000	-327,675,000	-324,025,000	-319,115,000	-314,699,000	-312,547,000
total shareholders’ equity	306,809,000	295,487,000	291,967,000	257,472,000	242,977,000	233,896,000	225,952,000	204,380,000	198,928,000	193,978,000	192,272,000	177,837,000	174,816,000	172,485,000	170,462,000	156,780,000	151,092,000	140,209,000	134,260,000	114,630,000	107,596,000	110,452,000	111,091,000	96,990,000	88,542,000	103,055,000	102,231,000	94,475,000	90,598,000	20,935,000	22,540,000	16,737,000	13,973,000	15,504,000	24,708,000	11,393,000	17,107,000	19,226,000	22,130,000	26,410,000	30,244,000	31,702,000	35,641,000	37,784,000	2,785,000	3,769,000	3,894,000	4,950,000										-1,446,000	17,791,000	22,622,000	17,284,000	19,818,000	23,334,000	28,228,000	28,251,000	32,276,000	42,342,000	22,384,000	33,028,000	36,204,000		11,626,000					10,894,000
total liabilities and shareholders’ equity	435,608,000	424,587,000	432,722,000	390,405,000	376,839,000	356,661,000	353,657,000	318,125,000	310,711,000	265,096,000	273,003,000	248,017,000	244,815,000	240,288,000	243,705,000	224,143,000	221,945,000	211,464,000	205,608,000	157,504,000	146,691,000	150,265,000	153,238,000	137,527,000	125,826,000	141,229,000	118,689,000	124,463,000	122,193,000	52,409,000	54,577,000	40,278,000	36,534,000	40,588,000	48,598,000	28,022,000	29,434,000	33,057,000	34,309,000	35,818,000	41,219,000	44,492,000	47,579,000	50,381,000	19,836,000	9,878,000									7,739,000	14,072,000	20,304,000	26,231,000	20,531,000	24,569,000	19,276,000	21,955,000	26,217,000	30,962,000	32,848,000	34,569,000	44,881,000	24,081,000	33,897,000	37,005,000		12,171,000					11,905,000
accumulated other comprehensive loss			4,000		-273,000	-245,000	-100,000	-463,000	-621,000	-636,000	-978,000	-1,146,000	-855,000	-613,000
accumulated other comprehensive income															-154,000	-23,000	-23,000	-47,000	14,000
other liabilities																41,000	41,000	41,000	41,000	41,000	41,000	41,000	41,000	35,000	34,000	176,000
right-of-use leased assets																				24,796,000	23,800,000
other comprehensive gain																				78,000	146,000	62,000	21,000	29,000	38,000	3,000
short term investments																					25,086,000	35,957,000	42,829,000			49,001,000	64,638,000	44,462,000
long term investments																						1,720,000	9,247,000
warrants																									104,000	104,000	104,000	302,000	302,000	397,000	397,000	190,000	190,000	190,000	190,000	190,000
deferred rent																											566,000	534,000	503,000
warrant liabilities																													1,549,000	1,921,000	1,014,000	1,269,000	209,000	650,000	757,000	658,000	455,000	2,397,000	757,000	825,000	1,286,000	1,398,000	1,081,000	1,209,000	2,974,000	3,226,000	2,019,000	4,025,000	31,000	376,000	1,995,000	2,954,000	7,221,000	17,525,000	16,625,000	21,668,000	27,164,000	24,700,000
current portion of term loan credit agreement																												4,097,000	2,848,000	1,597,000	350,000	2,557,000
other																											188,000	189,000	198,000	159,000	181,000	216,000	215,000	291,000	259,000	39,000	39,000	136,000	160,000	130,000	154,000	180,000	210,000
revolving and term loan credit agreement																												13,183,000	14,416,000	15,649,000	16,888,000	7,400,000
other comprehensive loss																											-39,000	-18,000												-71,000	-71,000	-71,000
cash																														29,777,000	26,862,000	15,466,000	14,041,000	19,847,000	22,978,000	8,880,000	9,835,000	13,544,000	14,581,000	18,724,000	20,218,000	25,903,000	30,343,000	37,578,000	7,263,000	8,836,000	8,059,000
short term deferred rent																														426,000	420,000
long term deferred rent																														1,947,000	2,059,000	1,613,000	1,567,000	1,632,000	1,687,000
other long term debt																																	11,000	21,000	32,000
series b-2 non-voting convertible preferred stock, no par value: shares authorized and reserved — 39; shares issued and outstanding — 0 and 12, respectively
series b-2 voting convertible preferred stock, no par value: shares authorized and reserved — 39, shares issued and outstanding — 0 and 12, respectively
current portion of term loan credit agreement, net of deferred costs of 110																																	2,112,000	1,446,000	779,000
revolving and term loan credit agreement, net of deferred costs of 238 and 293, respectively																																	8,040,000
revolving and term loan credit agreement, net of deferred costs of 265 and 293, respectively																																		8,679,000
series b-2 voting convertible preferred stock, no par value: shares authorized and reserved — 39, shares issued and outstanding — 0 and12, respectively
revolving and term loan credit agreement, net of deferred costs of 293																																			9,318,000
series a non-voting convertible preferred stock, no par value: shares authorized and reserved — 1; shares issued and outstanding — 0 and 1, respectively
series b-2 voting convertible preferred stock, no par value: shares authorized and reserved — 39, shares issued and outstanding — 12																																			38,389,000	38,389,000	38,389,000	38,389,000	38,389,000	38,389,000	38,389,000	38,389,000	38,389,000	38,389,000	38,389,000	38,389,000
treasury stock																																				-3,150,000	-3,150,000	-3,150,000	-3,150,000
revolving and term loan credit agreement, net of deferred costs of 433																																				5,566,000
short-term deferred rent																																				232,000	460,000
long-term deferred rent																																				1,227,000	820,000
long term debt																																				42,000	52,000	62,000	71,000	81,000	91,000	100,000
series a non-voting convertible preferred stock, no par value: shares authorized and reserved — 1; shares issued and outstanding — 1																																				3,150,000	3,150,000	3,150,000	3,150,000
revolving credit agreement, net of deferred costs of 96																																					2,304,000
long term liabilities																																											109,000
accounts payable and accrued expenses																																												3,390,000	9,845,000	2,475,000	2,676,000	2,918,000	3,334,000	3,015,000	3,247,000	3,244,000	3,784,000	3,384,000	2,963,000	2,448,000	2,464,000	2,308,000	1,749,000	1,161,000	853,000	884,000	907,000	981,000	1,823,000	1,012,000	1,084,000	638,000	533,000	614,000	382,000	380,000	406,000	391,000	589,000	741,000	856,000
accrued employee benefits																																												2,176,000	1,732,000	406,000	620,000	299,000	458,000	858,000	383,000	742,000	945,000	1,398,000	1,042,000	1,014,000	688,000	467,000	686,000	358,000	355,000	355,000	747,000	417,000	1,238,000	1,281,000	1,455,000	1,059,000	336,000	187,000	176,000	165,000	174,000
verigen payment liability																																												3,158,000
restructuring reserve and asset retirement obligation																																												2,511,000
current portion of long-term debt																																												38,000		2,000	6,000	10,000	19,000	27,000	34,000	40,000	40,000	40,000	40,000	51,000	103,000	159,000	226,000	291,000	479,000	471,000	446,000	438,000	439,000
long term debt:																																												115,000
other comprehensive income																																													5,000
short-term debt																																													2,500,000
deficit accumulated during the development stage																																																										-227,168,000	-213,552,000	-208,437,000	-195,823,000	-191,865,000	-179,877,000	-175,014,000	-159,744,000	-154,915,000	-142,150,000		-125,675,000	-122,315,000	-113,864,000	-111,117,000	-103,376,000	-100,638,000	-93,797,000	-91,843,000	-85,858,000
liabilities, convertible preferred stock and shareholders’ equity
long-term debt																																																		2,000	6,000	9,000	19,000	29,000	40,000	49,000	43,000	43,000	79,000	137,000	305,000	427,000	783,000	898,000	1,097,000
series b-1 non-voting convertible preferred stock, no par value; shares authorized and reserved — 39; shares issued and outstanding - zero
series b-2 voting convertible preferred stock, no par value; shares authorized and reserved — 39; shares issued and outstanding — 12 and zero, respectively
total convertible preferred stock																																																	42,876,000	42,876,000	41,613,000	40,358,000
shareholders’ equity
series b-2 voting convertible preferred stock, no par value; shares authorized and reserved — 39; shares issued and outstanding — zero and 12, respectively																																															38,389,000
total liabilities, convertible preferred stock and shareholders’ equity																																															9,215,000	12,202,000
series b-1 non-voting convertible preferred stock, no par value; shares authorized and reserved — 39, shares issued and outstanding — zero																																																	5,186,000	5,186,000
series b-2 voting convertible preferred stock, no par value; shares authorized and reserved — 39, shares issued and outstanding —12 and zero, respectively
series b-2 voting convertible preferred stock, no par value: shares authorized and reserved — 39, shares issued and outstanding — zero and 12, respectively																																																38,389,000
liabilities, convertible preferred stock and shareholders’ deficit
series b-2 voting convertible preferred stock, no par value; shares authorized and reserved — 39, shares issued and outstanding —12																																																	37,690,000	37,690,000
shareholders’ deficit:
total shareholders’ deficit
total liabilities, convertible preferred stock and shareholders’ deficit																																																	5,683,000	10,582,000	15,178,000	22,708,000	30,439,000	38,664,000
revenues:
product sales and rentals																																																	3,000	8,000	9,000			2,000
research and development agreements
grants																																																			244,000
total revenues																																																	3,000	8,000	253,000			2,000
costs and expenses:
cost of product sales and rentals																																																	1,000	2,000	2,000			2,000
research and development																																																	3,676,000	5,538,000	8,609,000	6,147,000	7,069,000	6,796,000
selling, general and administrative																																																	1,560,000	1,633,000	3,265,000	2,138,000	2,231,000	1,762,000
total costs and expenses																																																	5,237,000	7,173,000	11,876,000	8,285,000	9,300,000	8,560,000
income from operations
other income:
decrease in fair value of warrants																																																	345,000			2,241,000
other income
interest income																																																	3,000	5,000	40,000	14,000	20,000	6,000
interest expense
total other income																																																	345,000	1,621,000		2,251,000	1,965,000
net income																																																			-19,088,000
accretion of convertible preferred stock																																																		1,263,000		1,218,000	1,231,000	289,000
net income attributable to common shareholders																																																	-4,889,000	-6,807,000	-19,088,000	-7,252,000	-8,566,000	-9,744,000
net income per share																																																	-110	-150	-650	-170	-220	-250
weighted-average number of common shares outstanding																																																	45,664,000	44,864,000	29,186,000	43,336,000	38,882,000	38,742,000
increase in fair value of warrants																																																		1,619,000			1,948,000
receivables																																																			28,000	9,000	9,000	11,000	9,000	9,000		18,000	16,000		58,000	254,000	18,000	63,000	78,000	96,000	139,000	192,000	193,000	259,000	246,000	276,000	350,000	320,000	120,000	145,000	129,000
series b-1 non-voting convertible preferred stock, no par value; shares authorized and reserved — zero and 39, respectively; shares issued and outstanding - zero																																																			3,923,000
series b-2 voting convertible preferred stock, no par value; shares authorized and reserved — zero and 39, respectively; shares issued and outstanding — zero and 12, respectively																																																			37,690,000		37,690,000
series b-1 non-voting convertible preferred stock, no par value; shares authorized and reserved — 39, at september 30, 2012, shares issued and outstanding — zero																																																				2,668,000
series b-2 voting convertible preferred stock, no par value; shares authorized and reserved — 39 at september 30, 2012, shares issued and outstanding —12, at september 30, 2012																																																				37,690,000
series b-1 non-voting convertible preferred stock, no par value; shares authorized and reserved — zero and 39, respectively; shares issued and outstanding — zero																																																					1,450,000
series b-1 non-voting convertible preferred stock, no par value; shares authorized and reserved — zero and 39, respectively; shares issued and outstanding — zero and 12, respectively																																																						38,012,000
total shareholders’deficit
inventories																																																													1,000				8,000	8,000	1,000	3,000	116,000			678,000
103,392,328, respectively deficit accumulated during the development stage																																																																				-137,854,000
property																																																																									302,000	322,000	206,000	233,000	179,000
accrued employee expenses																																																																										167,000	161,000	176,000	155,000
commitments

We provide you with 20 years of balance sheets for Vericel stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Vericel. Explore the full financial landscape of Vericel stock with our expertly curated balance sheets.

The information provided in this report about Vericel stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.